Medroxyprogesterone Acetate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 18 USDMF, 7 CEP/COS, 1 JDMF, 5 KDMF, 16 NDC API, 18 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

4 Intermediates Suppliers

4 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

154 FDF Dossiers, 41 FDA Orange Book, 48 Europe, 14 Canada, 22 Australia, 17 South Africa, 12 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 2.5MG, TABLET;ORAL - 5MG, INJECTABLE;INJECTION - 100MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 400MG/ML, INJECTABLE;INJECTION - 150MG/ML

RELATED EXCIPIENT COMPANIES

1 Evonik, 4 SPI Pharma, 2 Seqens, 3 DKSH, 5 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 11 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 9 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 27 BASF, 1 Clariant, 3 Corel Pharma Chem, 4 DFE Pharma, 2 Finar, 10 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 20 Kerry, 12 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 15 Roquette, 8 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

59 Fillers, Diluents & Binders, 29 Direct Compression, 28 Coating Systems & Additives, 25 Solubilizers, 23 Controlled & Modified Release, 22 Thickeners and Stabilizers, 19 Lubricants & Glidants, 18 Granulation, 17 Parenteral, 16 Co-Processed Excipients, 16 Topical, 11 Film Formers & Plasticizers, 11 Taste Masking, 10 Disintegrants & Superdisintegrants, 5 Emulsifying Agents, 5 Chewable & Orodispersible Aids, 4 Surfactant & Foaming Agents, 3 Coloring Agents, 3 Rheology Modifiers, 1 API Stability Enhancers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 19 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 39 Finished Drug Prices

MARKET PLACE

8 APIs, 6 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 Health Canada Patents

1 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 3 USP, 4 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 20246 / DOSAGE - INJECTABLE;INJECTION - 150MG/ML

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
MEDROXYPROGESTERONE ACETATE(UNII: C2QI4IOI2G) (MEDROXYPROGESTERONE - UNII:HSU1C9YRES)	MEDROXYPROGESTERONE ACETATE	150mg in 1

Inactive Ingredients

Ingredient Name	A-S Medication Solutions	A-S Medication Solutions LLC	Afaxys Pharma, LLC	Cipla USA Inc.	Mylan Institutional LLC	NorthStar RxLLC	REMEDYREPACK INC.	Sun Pharmaceutical Industries, Inc.	Bryant Ranch Prepack	NuCare Pharmaceuticals,Inc.	Northstar RxLLC	REMEDYREPACK INC.
HYDROCHLORIC ACID(QTT17582CB)
METHYLPARABEN(A2I8C7HI9T)
POLYETHYLENE GLYCOL 3350(G2M7P15E5P)
POLYSORBATE 80(6OZP39ZG8H)
PROPYLPARABEN(Z8IX2SC1OH)
SODIUM CHLORIDE(451W47IQ8X)
SODIUM HYDROXIDE(55X04QC32I)
WATER(059QF0KO0R)

Drug Product Composition: Medroxyprogesterone Acetate